MT. KISCO, N.Y., May 29, 2013 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. ( IMMD ) announced today that the company has appointed  Joseph V. DiTrolio , M.D. as the  Chief Medical Officer , United States.

Dr.  DiTrolio is a Diplomate of the  American Board of Urology , a Clinical Professor of Surgery, Division of Urology at  New Jersey Medical School , the Treasurer, Board of Governors for the Stone Center of New Jersey, and the immediate past Chairman of the Department of Urology for the  St. Barnabas Medical Center Healthcare System . Dr. DiTrolio has served as a medical consultant for Fortune 500 Healthcare companies including Novartis, Sanofi-Aventis, AstraZeneca, and Allergan.

Dr. DiTrolio commented, "After extensive research, I am very excited about ImmuDyne's future. I believe my Corporate relationships, along with my medical experience, will be quite beneficial to the Company and our shareholders, both in the short- and long-term."

President and  CEO Mark McLaughlin stated, "We are honored that Dr. DiTrolio chose to bring his world-class talents to ImmuDyne. In our opinion, this is a watershed moment. We expect Joe to play an integral role in ImmuDyne's growing future."

Karen Kingston, Chief Marketing Officer went on to say, "Dr. DiTrolio has joined our team at a critical time as the company enters into new areas of expansion and growth. In the immediate future, we will look to Dr. DiTrolio's expertise and guidance as ImmuDyne prepares to rollout new dietary supplement product lines through physician networks and practices."

http://finance.yahoo.com/news/immudyne-appoin...00469.html